affinity antibody

af·fin·i·ty an·ti·bod·y

the strength of binding between an antibody and an antigen. This interaction is reversible or avidity between antigen and antibody molecules, determined by the degree of complementary fit between the immunogenic region of the antigen and the binding site on the immunoglobulin molecule.
References in periodicals archive ?
Protelica's business model for commercializing the library is to work closely with industry partners to uncover new high affinity antibody mimics directed towards targets of clinical and diagnostic significance," says Mike Honeysett, Protelica's Chief Business Officer.
Kymab, a monoclonal antibody biopharmaceutical company, announced today the launch of Kymouse HK, the first strain from the innovative Kymouse[TM] antibody discovery platform, which enables rapid discovery of high affinity antibody drug candidates.
These platforms harness the power of the in vivo immune system to yield very high affinity antibody drug candidates with desirable characteristics of potency, specificity, solubility and reduced chances of immunogenicity.